FDA Approves Tecentriq with Lurbinectedin for Lung Cancer
October 3, 2025
Genentech, part of the Roche Group, announced that the U.S. Food and Drug Administration has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab with hyaluronidase-tqjs) combined